Ddfg, Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Ddfg, Inc
- $324 Billion
- Q2 2024
A detailed history of Ddfg, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ddfg, Inc holds 14,728 shares of ARWR stock, worth $277,180. This represents 0.12% of its overall portfolio holdings.
Number of Shares
14,728
Previous 14,728
-0.0%
Holding current value
$277,180
Previous $421 Million
9.13%
% of portfolio
0.12%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$295 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$230 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$167 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$110 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$77.9 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.99B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...